ZD4054: A Specific Endothelin A Receptor Antagonist with Promising Activity in Metastatic Castration-Resistant Prostate Cancer

Por Warren, Ruth, Liu, Glenn
Publicado em 2008

Beyond Taxanes: A Review of Novel Agents That Target Mitotic Tubulin and Microtubules, Kinases, and Kinesins

Por Harrison, Michael R., Holen, Kyle D., Liu, Glenn
Publicado em 2009

Optimizing a (18)F-NaF and (18)F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer

Por Simoncic, Urban, Perlman, Scott, Liu, Glenn, Jeraj, Robert
Publicado no Nucl Med Commun (2015)

High resolution ultrasound features of prostatic rib metastasis: A prospective feasibility study with implication in the high-risk prostate cancer patient

Por Lee, Kenneth S., De Smet, Arthur A., Liu, Glenn, Staab, Mary Jane
Publicado em 2013

Phase II Trial of Weekly Ixabepilone in Men With Metastatic Castrate-Resistant Prostate Cancer (E3803): A Trial of the Eastern Cooperative Oncology Group

Por Liu, Glenn, Chen, Yu-Hui, DiPaola, Robert, Carducci, Michael, Wilding, George
Publicado em 2012

An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer (CRPC)

Por Liu, Glenn, Kelly, W Kevin, Wilding, George, Leopold, Lance, Brill, Kimberli, Somer, Bradley
Publicado em 2009

A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer

Por Schelman, William R., Liu, Glenn, Wilding, George, Morris, Thomas, Phung, De, Dreicer, Robert
Publicado em 2009

In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis

Por Yang, Yunan, Zhang, Yin, Hong, Hao, Liu, Glenn, Leigh, Bryan R., Cai, Weibo
Publicado em 2011

Comparison of NaF and FDG PET/CT for assessment of treatment response in castrate-resistant prostate cancers with osseous metastases

Por Simoncic, Urban, Perlman, Scott, Liu, Glenn, Staab, Mary Jane, Straus, Jane, Jeraj, Robert
Publicado no Clin Genitourin Cancer (2014)

Atrasentan in Patients with Advanced Renal Cell Carcinoma: A Phase II Trial of the ECOG-ACRIN Cancer Research Group (E6800)

Por Carducci, Michael A., Manola, Judith, Nair, Suresh G., Liu, Glenn, Rousey, Steven, Dutcher, Janice P., Wilding, George
Publicado no Clin Genitourin Cancer (2015)

PET Imaging of VEGFR-2 Expression in Lung Cancer with (64)Cu-Labeled Ramucirumab

Por Luo, Haiming, England, Christopher G., Graves, Stephen A., Sun, Haiyan, Liu, Glenn, Nickles, Robert J., Cai, Weibo
Publicado no J Nucl Med (2015)

(18)F-FLT PET/CT imaging in patients with advanced solid malignancies treated with axitinib on an intermittent dosing regimen

Por Scarpelli, Matthew, Bruce, Justine Yang, Carmichael, Lakeesha, Eickhoff, Jens, Kolesar, Jill, Perlman, Scott, Jeraj, Robert, Liu, Glenn
Publicado no Cancer Chemother Pharmacol (2016)

Phase I study of continuous MKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalati...

Por Tevaarwerk, Amye, Wilding, George, Eickhoff, Jens, Chappell, Rick, Sidor, Carolyn, Arnott, Jamie, Bailey, Howard, Schelman, William, Liu, Glenn
Publicado em 2011

Phase I Trial of 2-Methoxyestradiol (2ME2, Panzem(®)) NanoCrystal(®) Dispersion (NCD(®)) in Advanced Solid Malignancies

Por Tevaarwerk, Amye J., Holen, Kyle D., Alberti, Dona B., Sidor, Carolyn, Arnott, Jamie, Quon, Check, Wilding, George, Liu, Glenn
Publicado em 2009

A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing...

Por Bruce, Justine Yang, Eickhoff, Jens, Pili, Roberto, Logan, Theodore, Carducci, Michael, Arnott, Jamie, Treston, Anthony, Wilding, George, Liu, Glenn
Publicado em 2010

A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancer

Por Cetnar, Jeremy, Wilding, George, McNeel, Douglas, LoConte, Noelle K., McFarland, Thomas A., Eickhoff, Jens, Liu, Glenn
Publicado em 2011

Differentiation of metastatic vs degenerative joint disease using semi-quantitative analysis with (18)F-NaF PET/CT in castrate resistant prostate cancer patients

Por Muzahir, Saima, Jeraj, Robert, Liu, Glenn, Hall, Lance T, Rio, Alejandro Munoz Del, Perk, Timothy, Jaskowiak, Christine, Perlman, Scott B
Publicado no Am J Nucl Med Mol Imaging (2015)

Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer

Por McNeel, Douglas G., Smith, Heath A., Eickhoff, Jens C., Lang, Joshua M., Staab, Mary Jane, Wilding, George, Liu, Glenn
Publicado em 2011

Vorinostat in Advanced Prostate Cancer Patients Progressing on Prior Chemotherapy (NCI Trial # 6862): Trial results and IL-6 analysis. A study by the DOD Prostate Cancer Clinical T...

Por Bradley, Deborah, Rathkopf, Dana, Dunn, Rodney, Stadler, Walter M., Liu, Glenn, Smith, David C., Pili, Roberto, Zwiebel, James, Scher, Howard, Hussain, Maha
Publicado em 2009

Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds α(5)β(1) Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study

Por Ricart, Alejandro D., Tolcher, Anthony W., Liu, Glenn, Holen, Kyle, Schwartz, Garry, Albertini, Mark, Weiss, Geoffrey, Yazji, Salim, Ng, Chee, Wilding, George
Publicado em 2008